Bio-Techne (TECH) Change in Acquisitions & Divestments (2009 - 2024)
Bio-Techne's (TECH) quarterly Change in Acquisitions & Divestments came in at $1.1 million in Q3 2024, down 95.43% year-on-year from $23.8 million in Q4 2023, and down 74.91% quarter-over-quarter from $4.3 million in Q2 2024.
Bio-Techne (TECH) Change in Acquisitions & Divestments (2009 - 2024) Analysis & Trends
Bio-Techne's Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at $1.1 million for Q3 2024.
- On a quarterly basis, Change in Acquisitions & Divestments fell 95.43% year-over-year to $1.1 million in Q3 2024; TTM through Jun 2025 was $1.1 million, a 96.14% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 96.14% from the prior year.
- Change in Acquisitions & Divestments retreated to $1.1 million in Q3 2024 per TECH's latest filing, from $4.3 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $58.7 million in Q4 2022 and bottomed at -$44.1 million in Q1 2023.
- The 5-year median for Change in Acquisitions & Divestments is $18.9 million (2021), against an average of $19.5 million.
- Across the five-year window, Change in Acquisitions & Divestments jumped 460.33% in 2020 and slumped 423.84% in 2023, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $14.1 million in 2020, then decreased by 11.75% to $12.4 million in 2021, then soared by 371.57% to $58.7 million in 2022, then sank by 59.53% to $23.8 million in 2023, then tumbled by 95.43% to $1.1 million in 2024.
- Per Business Quant, the three latest TECH Change in Acquisitions & Divestments figures stand at $1.1 million (Q3 2024), $4.3 million (Q2 2024), and $23.8 million (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 4.32 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Jun 30, 2023 | 44.06 Mn |
| Jun 30, 2023 | 44.06 Mn |
| Mar 31, 2023 | -44.06 Mn |
| Mar 31, 2023 | -44.06 Mn |
| Dec 31, 2022 | 58.71 Mn |
| Dec 31, 2022 | 58.71 Mn |
| Sep 30, 2022 | 14.51 Mn |
| Sep 30, 2022 | 14.51 Mn |
| Mar 31, 2022 | 13.61 Mn |
| Mar 31, 2022 | 13.61 Mn |
| Sep 30, 2021 | 12.45 Mn |
| Sep 30, 2021 | 12.45 Mn |
| Mar 31, 2021 | 23.23 Mn |
| Mar 31, 2021 | 23.23 Mn |